Trademark: 90868359
Word
ADEPT
Status
Pending
Status Code
760
Status Date
Thursday, August 24, 2023
Serial Number
90868359
Mark Type
4000
Filing Date
Thursday, August 5, 2021

Trademark Owner History

Classifications
9 Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers; all of the foregoing for use in the field of genetic analysis
5 Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; all of the foregoing for use in the field of genetic analysis
1 Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes; all of the foregoing for use in the field of genetic analysis
10 Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers for use in the field of genetic analysis

Trademark Events
Jan 30, 2024
Exparte Appeal Affirmed/Reversed In Part
Sep 12, 2023
Reply Brief Filed - Check Ttab Files
Aug 24, 2023
Notification Of Examiners Statement E-Mailed
Aug 24, 2023
Examiners Statement E-Mailed
Aug 24, 2023
Examiners Statement - Completed
Jun 28, 2023
Jurisdiction Restored To Examining Attorney
Apr 27, 2023
Notification Of Action Denying Req For Recon E-Mailed
Apr 27, 2023
Action Denying Req For Recon E-Mailed
Apr 27, 2023
Action Continuing Final - Completed
Mar 27, 2023
Teas Request For Reconsideration Received
Mar 27, 2023
Ex Parte Appeal-Instituted
Mar 27, 2023
Jurisdiction Restored To Examining Attorney
Mar 27, 2023
Exparte Appeal Received At Ttab
Sep 29, 2022
Notification Of Final Refusal Emailed
Sep 29, 2022
Final Refusal E-Mailed
Sep 29, 2022
Final Refusal Written
Sep 1, 2022
Teas/Email Correspondence Entered
Aug 31, 2022
Correspondence Received In Law Office
Aug 31, 2022
Teas Response To Office Action Received
Mar 7, 2022
Notification Of Non-Final Action E-Mailed
Mar 7, 2022
Non-Final Action E-Mailed
Mar 7, 2022
Non-Final Action Written
Feb 28, 2022
Assigned To Examiner
Sep 30, 2021
New Application Office Supplied Data Entered
Aug 9, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24